Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: A "poison pill" stillpoint21
2
Jan 15, 2008 08:58AM
1
Jan 15, 2008 09:09AM

As I posted before, figures were given for subsequent licensing tiers, along with graphs and charts. TPL have therefore indicated a valuation on the MMP Portfolio. For them to bid for the 50% of PDS that belongs to PTSC, that presentation would be the basis of a "fair" price. This would also be applicable for any 3rd party bid.

TPL have set the valuation of PDS to the benefit of PTSC shareholders without possibly realizing it. The poison pill lies in their valuation of a fair price, which will be challenged in the Delaware Chancery Court if any offer falls short.

Be well

1
Jan 15, 2008 10:16AM
2
Jan 15, 2008 11:24AM
2
Jan 15, 2008 09:51PM
4
Feb 10, 2008 09:13AM

Feb 10, 2008 09:21AM
1
Feb 10, 2008 09:34AM
Share
New Message
Please login to post a reply